Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines
Abstract Background: Ovarian cancer is a significant cancer-related cause of death in women worldwide. The most used chemotherapeutic regimen is based on carboplatin (CBDCA). However, CBDCA resistance is the main obstacle to a better prognosis. An in vitro drug-resistant cell model would help in th...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2019
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100211 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0716-97602019000100211 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0716-976020190001002112019-10-10Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell linesViscarra,TamaraBuchegger,KurtJofre,IgnacioRiquelme,IsmaelZanella,LouiseAbanto,MichelParker,Alyssa C.Piccolo,Stephen R.Roa,Juan CarlosIli,CarmenBrebi,Priscilla A2780 cell line Carboplatin Drug resistance Wnt/β-catenin-signaling pathway Integrin signaling pathway Ovarian cancer Abstract Background: Ovarian cancer is a significant cancer-related cause of death in women worldwide. The most used chemotherapeutic regimen is based on carboplatin (CBDCA). However, CBDCA resistance is the main obstacle to a better prognosis. An in vitro drug-resistant cell model would help in the understanding of molecular mechanisms underlying this drug-resistance phenomenon. The aim of this study was to characterize cellular and molecular changes of induced CBDCA-resistant ovarian cancer cell line A2780. Methods: The cell selection strategy used in this study was a dose-per-pulse method using a concentration of 100 μM for 2 h. Once 20 cycles of exposure to the drug were completed, the cell cultures showed a resistant phenotype. Then, the ovarian cancer cell line A2780 was grown with 100 μM of CBDCA (CBDCA-resistant cells) or without CBDCA (parental cells). After, a drug sensitivity assay, morphological analyses, cell death assays and a RNA-seq analysis were performed in CBDCA-resistant A2780 cells. Results: Microscopy on both parental and CBDCA-resistant A2780 cells showed similar characteristics in morphology and F-actin distribution within cells. In cell-death assays, parental A2780 cells showed a significant increase in phosphatidylserine translocation and caspase-3/7 cleavage compared to CBDCA-resistant A2780 cells (P < 0.05 and P < 0.005, respectively). Cell viability in parental A2780 cells was significantly decreased compared to CBDCA-resistant A2780 cells (P < 0.0005). The RNA-seq analysis showed 156 differentially expressed genes (DEGs) associated mainly to molecular functions. Conclusion: CBDCA-resistant A2780 ovarian cancer cells is a reliable model of CBDCA resistance that shows several DEGs involved in molecular functions such as transmembrane activity, protein binding to cell surface receptor and catalytic activity. Also, we found that the Wnt/3-catenin and integrin signaling pathway are the main metabolic pathway dysregulated in CBDCA-resistant A2780 cells.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.52 20192019-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100211en10.1186/s40659-019-0220-0 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
English |
topic |
A2780 cell line Carboplatin Drug resistance Wnt/β-catenin-signaling pathway Integrin signaling pathway Ovarian cancer |
spellingShingle |
A2780 cell line Carboplatin Drug resistance Wnt/β-catenin-signaling pathway Integrin signaling pathway Ovarian cancer Viscarra,Tamara Buchegger,Kurt Jofre,Ignacio Riquelme,Ismael Zanella,Louise Abanto,Michel Parker,Alyssa C. Piccolo,Stephen R. Roa,Juan Carlos Ili,Carmen Brebi,Priscilla Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines |
description |
Abstract Background: Ovarian cancer is a significant cancer-related cause of death in women worldwide. The most used chemotherapeutic regimen is based on carboplatin (CBDCA). However, CBDCA resistance is the main obstacle to a better prognosis. An in vitro drug-resistant cell model would help in the understanding of molecular mechanisms underlying this drug-resistance phenomenon. The aim of this study was to characterize cellular and molecular changes of induced CBDCA-resistant ovarian cancer cell line A2780. Methods: The cell selection strategy used in this study was a dose-per-pulse method using a concentration of 100 μM for 2 h. Once 20 cycles of exposure to the drug were completed, the cell cultures showed a resistant phenotype. Then, the ovarian cancer cell line A2780 was grown with 100 μM of CBDCA (CBDCA-resistant cells) or without CBDCA (parental cells). After, a drug sensitivity assay, morphological analyses, cell death assays and a RNA-seq analysis were performed in CBDCA-resistant A2780 cells. Results: Microscopy on both parental and CBDCA-resistant A2780 cells showed similar characteristics in morphology and F-actin distribution within cells. In cell-death assays, parental A2780 cells showed a significant increase in phosphatidylserine translocation and caspase-3/7 cleavage compared to CBDCA-resistant A2780 cells (P < 0.05 and P < 0.005, respectively). Cell viability in parental A2780 cells was significantly decreased compared to CBDCA-resistant A2780 cells (P < 0.0005). The RNA-seq analysis showed 156 differentially expressed genes (DEGs) associated mainly to molecular functions. Conclusion: CBDCA-resistant A2780 ovarian cancer cells is a reliable model of CBDCA resistance that shows several DEGs involved in molecular functions such as transmembrane activity, protein binding to cell surface receptor and catalytic activity. Also, we found that the Wnt/3-catenin and integrin signaling pathway are the main metabolic pathway dysregulated in CBDCA-resistant A2780 cells. |
author |
Viscarra,Tamara Buchegger,Kurt Jofre,Ignacio Riquelme,Ismael Zanella,Louise Abanto,Michel Parker,Alyssa C. Piccolo,Stephen R. Roa,Juan Carlos Ili,Carmen Brebi,Priscilla |
author_facet |
Viscarra,Tamara Buchegger,Kurt Jofre,Ignacio Riquelme,Ismael Zanella,Louise Abanto,Michel Parker,Alyssa C. Piccolo,Stephen R. Roa,Juan Carlos Ili,Carmen Brebi,Priscilla |
author_sort |
Viscarra,Tamara |
title |
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines |
title_short |
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines |
title_full |
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines |
title_fullStr |
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines |
title_full_unstemmed |
Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell lines |
title_sort |
functional and transcriptomic characterization of carboplatin-resistant a2780 ovarian cancer cell lines |
publisher |
Sociedad de Biología de Chile |
publishDate |
2019 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602019000100211 |
work_keys_str_mv |
AT viscarratamara functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT bucheggerkurt functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT jofreignacio functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT riquelmeismael functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT zanellalouise functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT abantomichel functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT parkeralyssac functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT piccolostephenr functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT roajuancarlos functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT ilicarmen functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines AT brebipriscilla functionalandtranscriptomiccharacterizationofcarboplatinresistanta2780ovariancancercelllines |
_version_ |
1718441586238423040 |